Wersäll et al. demonstrated that pretreatment with IL-4 enhanced the ADCC activity of peripheral blood mononuclear cells (PBMCs), monocytes, and natural killer cells against SW948 CRC cells [76]. The gene discussed is IL4; the disease is colorectal carcinoma.